Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 383, Issue 22, Pages -Publisher
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMp2030033
Keywords
-
Categories
Ask authors/readers for more resources
If Black communities are to participate in Covid-19 trials, clinicians, investigators, and pharmaceutical companies must provide convincing evidence - sufficient to overcome the extensive historical evidence to the contrary - that they are, in fact, trustworthy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available